New green methods for making hydrogen fuels. Microrockets that can circulate in the human body without external fuel. Improved seismic safety in hospitals and other structures. New approaches to help utilities integrate solar power into the energy grid.
A 200-patient Phase 2 clinical pilot study will be initiated this month to test the efficacy and safety of a new use, and method of administering, an enzyme inhibitor for critically ill patients developed by University of California, San Diego Bioengineering Professor Geert Schmid-Schönbein.